MR-based biomarker in diagnosis and follow-up of Niemann-Pick C-disease.
Laufzeit: 01.01.2012 - 31.12.2015
Kurzfassung
The target if this clinical trial is to find and implement special MR-sequences in order to quantify the level of neurodegeneration in patients suffering from Nieman-Pick-disease type C. these special sequences include diffusion tensor imaging (DTI), MR spectroscopy and resting state fMRI.
